Noxafil 100 mg

Noxafil 100 mg is a medicine authorised by Swissmedic under authorisation number 63240. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 February 2015 and the authorisation is valid without a time limit. ATC code J02AC04 places the medicine in the group Antimycotics for systemic use.

  • Dispensing category B
  • Authorisation number 63240
  • ATC J02AC04
  • Synthetic medicines
Authorisation data
Authorisation number63240
NameNoxafil 100 mg
Full nameNoxafil 100 mg, magensaftresistente Tablette
Authorisation holderMSD Merck Sharp & Dohme AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeJ02AC04
First authorisation18 February 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Noxafil 100 mg, magensaftresistente TabletteB18 February 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
124Tablette(n)J02AC0408.06.0.B
296Tablette(n)J02AC0408.06.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Noxafil 100 mg authorised in Switzerland?

Yes. Noxafil 100 mg is authorised by Swissmedic under authorisation number 63240, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Noxafil 100 mg have?

Noxafil 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Noxafil 100 mg?

The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com